Multiple-Dose Escalation Study of the Safety, Pharmacokinetics, and Biologic Activity of Oral AMD070, a Selective CXCR4 Receptor Inhibitor, in Human Subjects

समान संसाधन

• Multiple-Dose Escalation Study of the Safety, Pharmacokinetics, and Biologic Activity of Oral AMD070, a Selective CXCR4 Receptor Inhibitor, in Human Subjects
  द्वारा: Stone, Nimalie D., और अन्य
  प्रकाशित: (2007)
• Effect of Low-Dose Ritonavir on the Pharmacokinetics of the CXCR4 Antagonist AMD070 in Healthy Volunteers
  द्वारा: Cao, Ying Jun, और अन्य
  प्रकाशित: (2008)
• Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers
  द्वारा: Hendrix, Craig W., और अन्य
  प्रकाशित: (2000)
• Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor): Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210
  द्वारा: Johnson, Victoria A., और अन्य
  प्रकाशित: (2019)
• AMD3100/CXCR4 inhibitor
  द्वारा: Erik eDe Clercq
  प्रकाशित: (2015-06-01)